PortfoliosLab logoPortfoliosLab logo
ASND vs. BE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ASND vs. BE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ascendis Pharma A/S (ASND) and Bloom Energy Corporation (BE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ASND achieves a 2.26% return, which is significantly lower than BE's 199.48% return.


ASND

1D
1.14%
1M
-10.48%
YTD
2.26%
6M
-1.07%
1Y
27.58%
3Y*
32.88%
5Y*
10.86%
10Y*
33.14%

BE

1D
4.56%
1M
-10.19%
YTD
199.48%
6M
173.97%
1Y
1,069.53%
3Y*
145.16%
5Y*
59.08%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ASND vs. BE - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
ASND
Ascendis Pharma A/S
2.26%54.89%9.31%3.13%-9.22%-19.34%19.88%122.06%-6.78%
BE
Bloom Energy Corporation
199.48%291.22%50.07%-22.59%-12.81%-23.48%283.67%-25.15%-46.63%

Correlation

The correlation between ASND and BE is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Jul 25, 2018

0.21

The correlation between ASND and BE shifts across timeframes, from 0.09 (1 year) to 0.25 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ASND:

$14.07B

BE:

$83.19B

EPS

ASND:

€8.08

BE:

$0.02

PE Ratio

ASND:

23.32

BE:

11.33K

PS Ratio

ASND:

13.62

BE:

27.91

PB Ratio

ASND:

24.89

BE:

90.28

Total Revenue (TTM)

ASND:

€867.51M

BE:

$2.45B

Gross Profit (TTM)

ASND:

€764.89M

BE:

$761.91M

EBITDA (TTM)

ASND:

-€6.94M

BE:

$88.83M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ASND vs. BE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASND
ASND Risk / Return Rank: 6868
Overall Rank
ASND Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
ASND Sortino Ratio Rank: 6363
Sortino Ratio Rank
ASND Omega Ratio Rank: 6060
Omega Ratio Rank
ASND Calmar Ratio Rank: 7272
Calmar Ratio Rank
ASND Martin Ratio Rank: 7676
Martin Ratio Rank

BE
BE Risk / Return Rank: 9999
Overall Rank
BE Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
BE Sortino Ratio Rank: 9898
Sortino Ratio Rank
BE Omega Ratio Rank: 9797
Omega Ratio Rank
BE Calmar Ratio Rank: 100100
Calmar Ratio Rank
BE Martin Ratio Rank: 100100
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASND vs. BE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and Bloom Energy Corporation (BE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ASNDBEDifference
Sharpe ratioReturn per unit of total volatility

-9.29

Sortino ratioReturn per unit of downside risk

-3.61

Omega ratioGain probability vs. loss probability

1.15

1.62

-0.47

Calmar ratioReturn relative to maximum drawdown

1.59

23.53

-21.94

Martin ratioReturn relative to average drawdown

4.87

73.01

-68.14

ASND vs. BE - Sharpe Ratio Comparison

The current ASND Sharpe Ratio is 0.75, which is lower than the BE Sharpe Ratio of 10.05. The chart below compares the historical Sharpe Ratios of ASND and BE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ASND vs. BE - Drawdown Comparison

The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum BE drawdown of -92.54%. Use the drawdown chart below to compare losses from any high point for ASND and BE.


Loading charts...

Drawdown Indicators


ASNDBEDifference

Max Drawdown

Largest peak-to-trough decline

-61.72%

-92.54%

+30.82%

Max Drawdown (1Y)

Largest decline over 1 year

-17.62%

-45.94%

+28.32%

Max Drawdown (3Y)

Largest decline over 3 years

-29.15%

-53.42%

+24.27%

Max Drawdown (5Y)

Largest decline over 5 years

-60.46%

-75.87%

+15.41%

Max Drawdown (10Y)

Largest decline over 10 years

-61.72%

Current Drawdown

Current decline from peak

-12.72%

-15.48%

+2.76%

Average Drawdown

Average peak-to-trough decline

-18.90%

-51.91%

+33.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.72%

14.78%

-9.06%

Volatility

ASND vs. BE - Volatility Comparison

The current volatility for Ascendis Pharma A/S (ASND) is 13.12%, while Bloom Energy Corporation (BE) has a volatility of 27.74%. This indicates that ASND experiences smaller price fluctuations and is considered to be less risky than BE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ASNDBEDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.12%

27.74%

-14.62%

Volatility (6M)

Calculated over the trailing 6-month period

29.45%

75.65%

-46.20%

Volatility (1Y)

Calculated over the trailing 1-year period

37.26%

107.62%

-70.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.65%

85.95%

-37.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

51.09%

95.68%

-44.59%

Dividends

ASND vs. BE - Dividend Comparison

Neither ASND nor BE has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ASND vs. BE - Financials Comparison

This section allows you to compare key financial metrics between Ascendis Pharma A/S and Bloom Energy Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20222023202420252026
250.66M
751.05M
(ASND) Total Revenue
(BE) Total Revenue
Please note, different currencies. ASND values in EUR, BE values in USD

Frequently Asked Questions


ASND and BE have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BE has higher volatility (27.74%) compared to ASND (13.12%). In terms of maximum drawdown, ASND dropped -61.72% vs BE's -92.54%.

BE currently has the higher Sharpe Ratio (10.05 vs 0.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ASND and BE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer